NEW YORK, Aug. 10 – Invitrogen has exclusively licensed lentiviral gene-delivery technology from Cell Genesys for use in gene-expression research and drug-target validation, the companies said on Friday.
Registering provides access to this and other free content.
Already have an account?Login Now.
The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.
In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.
Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.
Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.